공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

리서치사 QYResearch
발행일 2017년 12월 상품 코드 597667
페이지 정보 영문
가격
US $ 2,900 ₩ 3,301,000 PDF (Single User License)
US $ 5,800 ₩ 6,602,000 PDF (Enterprise Wide License)


세계의 바이러스 벡터 및 플라스미드 DNA 제조 시장 Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017
발행일 : 2017년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이러스 벡터 및 플라스미드 DNA 제조(Viral Vectors and Plasmid DNA Manufacturing) 시장에 대해 조사했으며, 시장 정의와 개요, 산업 체인과 제조 환경, 종류·용도·지역/주요 국가별 제조 매출 추정과 예측, 시장에 대한 각종 영향요인, 경쟁 상황과 시장 점유율, 주요 제조업체 개요 등의 정보를 전해드립니다.

제1장 시장 개요

  • 제품 개요
  • 시장 분석과 예측 : 종류별
    • 매출과 성장률 비교
    • 시장 점유율
    • 바이러스 벡터
    • 플라스미드 DNA
  • 시장 분석과 예측 : 용도별
    • 매출 비교
    • 유전성 질환
    • 바이러스 감염
  • 시장 분석과 예측 : 지역별
  • 시장 규모 예측

제2장 경쟁 분석 : 제조업체/브랜드별

  • 바이러스 벡터 제조 매출, 점유율 추정
  • 플라스미드 DNA 제조 매출, 점유율 추정
  • 총이익 추정
  • 주요 제조업체의 본사, 설립년, 제조 제품
  • 경쟁 상황과 동향

제3장 매출 추정 : 지역별

  • 매출, 점유율 추정
  • 매출, 점유율, 총이익, 비용 추정
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제4장 매출, 점유율, 성장률 추정 : 종류별

제5장 매출, 점유율, 성장률 추정 : 용도별

제6장 주요 제조업체 분석

  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Brammer Bio
  • VGXI
  • PlasmidFactory

제7장 제조 비용 분석

  • 원재료 분석
  • 비용 구조 분석
  • 제조 공정 분석

제8장 산업 체인, 조달 전략, 다운스트림 바이어

제9장 마케팅 전략, 유통 판매업체

  • 마케팅 경로
  • 시장 포지셔닝

제10장 시장 영향요인 분석

  • 기술 진보와 위험
  • 소비자 요구와 고객 선호의 변화
  • 정치 경제 환경의 변화

제11장 시장 예측

  • 제조 매출 예측
  • 제조 매출 예측 : 지역별
  • 제조 매출 예측 : 종류별
  • 제조 매출 예측 : 용도별

제12장 조사 결과와 결론

제13장 조사 방법과 데이터 소스

KSM 18.01.09

This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.

In the last several years, global market of Viral Vectors and Plasmid DNA Manufacturing developed rapidly, with an average growth rate of 28.05%. In 2016, global revenue of Viral Vectors and Plasmid DNA Manufacturing is nearly 250 M USD.

The major players in global Viral Vectors and Plasmid DNA Manufacturing market include:

  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Brammer Bio
  • VGXI
  • PlasmidFactory

Geographically, this report is segmented into several key Regions, with revenue, Market Share and Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast), covering:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into:

  • Plasmid DNA
  • Viral Vectors

On the basis on the end users/applications, this report covers:

  • Cancers
  • Inherited Disorders
  • Viral Infections
  • Other

Table of Contents

1. Viral Vectors and Plasmid DNA Manufacturing Market Overview

  • 1.1. Viral Vectors and Plasmid DNA Manufacturing Product Overview
  • 1.2. Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category)
    • 1.2.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022)
    • 1.2.2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016
    • 1.2.3. Viral Vectors
    • 1.2.4. Plasmid DNA
  • 1.3. Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications
    • 1.3.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022)
    • 1.3.2. Cancers
    • 1.3.3. Inherited Disorders
    • 1.3.4. Viral Infections
  • 1.4. Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions (2012-2022)
    • 1.4.1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Comparison by Regions (2012-2022)
    • 1.4.2. North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
    • 1.4.3. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
    • 1.4.4. Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
    • 1.4.5. South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
    • 1.4.6. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)
  • 1.5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2012-2022)

2. Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand

  • 2.1. Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017)
  • 2.2. Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017)
  • 2.3. Global Viral Vectors and Plasmid DNA Manufacturing Gross Margin by Manufacturers (2016-2017)
  • 2.4. Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters, Established Date, Product Types
  • 2.5. Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
    • 2.5.1. Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
    • 2.5.2. Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers
    • 2.5.3. Mergers. Acquisitions, Expansion

3. Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017)

  • 3.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions (2012-2017)
  • 3.2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
  • 3.3. North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
  • 3.4. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
  • 3.5. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
  • 3.6. South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)
  • 3.7. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)

4. Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types

  • 4.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017)
  • 4.2. Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)

5. Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications

  • 5.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Applications (2012-2017)
  • 5.2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)

6. Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers

  • 6.1. BioReliance
    • 6.1.1. Company Profile
    • 6.1.2. Product Information
    • 6.1.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.2. Cobra Biologics
    • 6.2.1. Company Profile
    • 6.2.2. Product Information
    • 6.2.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.3. Oxford BioMedica
    • 6.3.1. Company Profile
    • 6.3.2. Product Information
    • 6.3.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.4. UniQure
    • 6.4.1. Company Profile
    • 6.4.2. Product Information
    • 6.4.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.5. FinVector
    • 6.5.1. Company Profile
    • 6.5.2. Product Information
    • 6.5.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.6. MolMed
    • 6.6.1. Company Profile
    • 6.6.2. Product Information
    • 6.6.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.7. MassBiologics
    • 6.7.1. Company Profile
    • 6.7.2. Product Information
    • 6.7.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.8. Richter-Helm
    • 6.8.1. Company Profile
    • 6.8.2. Product Information
    • 6.8.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.9. FUJIFILM Diosynth Biotechnologies
    • 6.9.1. Company Profile
    • 6.9.2. Product Information
    • 6.9.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.10. Lonza
    • 6.10.1. Company Profile
    • 6.10.2. Product Information
    • 6.10.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.11. Aldevron
    • 6.11.1. Company Profile
    • 6.11.2. Product Information
    • 6.11.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.12. Eurogentec
    • 6.12.1. Company Profile
    • 6.12.2. Product Information
    • 6.12.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.13. Cell and Gene Therapy Catapult
    • 6.13.1. Company Profile
    • 6.13.2. Product Information
    • 6.13.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.14. Biovian
    • 6.14.1. Company Profile
    • 6.14.2. Product Information
    • 6.14.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.15. Brammer Bio
    • 6.15.1. Company Profile
    • 6.15.2. Product Information
    • 6.15.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.16. VGXI
    • 6.16.1. Company Profile
    • 6.16.2. Product Information
    • 6.16.3. Revenue, Cost, Gross Profit and Gross Margin
  • 6.17. PlasmidFactory
    • 6.17.1. Company Profile
    • 6.17.2. Product Information
    • 6.17.3. Revenue, Cost, Gross Profit and Gross Margin

7. Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis

  • 7.1. Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
    • 7.1.1. Key Raw Materials
    • 7.1.2. Key Suppliers of Raw Materials
  • 7.2. Proportion of Manufacturing Cost Structure
    • 7.2.1. Raw Materials
    • 7.2.2. Labor Cost Analysis
      • 7.2.2.1. USA Labor Cost Analysis
      • 7.2.2.2. Europe Labor Costs Analysis
      • 7.2.2.3. Asia Labor Costs Analysis
    • 7.2.3. Other Costs Analysis
      • 7.2.3.1. USA Cost of Electricity Analysis
      • 7.2.3.2. USA Water Cost Analysis
      • 7.2.3.3. Europe Cost of Electricity Analysis
      • 7.2.3.4. Europe Water Cost Analysis
      • 7.2.3.5. China Cost of Electricity Analysis
      • 7.2.3.6. China Water Cost Analysis
    • 7.2.4. Manufacturing Expenses
  • 7.3. Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

8. Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1. Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
  • 8.2. Upstream Raw Materials Sourcing
  • 8.3. Downstream Buyers

9. Marketing Strategy Analysis, Distributors/Traders

  • 9.1. Marketing Channel
    • 9.1.1. Direct Marketing
    • 9.1.2. Indirect Marketing
    • 9.1.3. Marketing Channel Development Trend
  • 9.2. Market Positioning
    • 9.2.1. Pricing Strategy
    • 9.2.2. Brand Strategy
    • 9.2.3. Target Client

10. Market Effect Factors Analysis

  • 10.1. Technology Progress in Related Industry
  • 10.2. Consumer Needs/Customer Preference Change
  • 10.3. Economic/Political Environmental Change

11. Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)

  • 11.1. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
  • 11.2. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Regions (2017-2022)
    • 11.2.1. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
    • 11.2.2. Europe Viral Vectors and Plasmid DNA Manufacturing and Revenue Forecast (2017-2022)
    • 11.2.3. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
    • 11.2.4. South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
    • 11.2.5. Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)
  • 11.3. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)
  • 11.4. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2017-2022)

12. Research Findings and Conclusion

13. Methodology and Data Source

  • 13.1. Methodology/Research Approach
    • 13.1.1. Research Programs/Design
    • 13.1.2. Market Size Estimation
    • 13.1.3. Market Breakdown and Data Triangulation
  • 13.2. Data Source
    • 13.2.1. Secondary Sources
    • 13.2.2. Primary Sources
  • 13.3. Disclaimer
  • 13.4. Author List

List of Tables and Figures

  • Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016
  • Figure Product Picture of Viral Vectors
  • Figure Product Picture of Plasmid DNA
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Applications (2012-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Applications in 2016
  • Figure Cancers Examples
  • Figure Inherited Disorders Examples
  • Figure Viral Infections Examples
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Comparison and Growth by Regions (2012-2022)
  • Table Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Regions 2012-2022
  • Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
  • Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Status and Outlook (2012-2022)
  • Table Global Viral Vectors Revenue (M USD) of Key Manufacturers (2016-2017)
  • Table Global Viral Vectors Manufacturing Revenue Share by Manufacturers (2016-2017)
  • Figure 2016 Viral Vectors Manufacturing Revenue Share by Manufacturers
  • Figure 2017 Viral Vectors Manufacturing Revenue Share by Manufacturers
  • Table Global Plasmid DNA Manufacturing Revenue (M USD) by Manufacturers (2016-2017)
  • Table Global Plasmid DNA Manufacturing Revenue Share by Manufacturers (2016-2017)
  • Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
  • Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
  • Table Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers (2016-2017)
  • Figure Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers in 2016
  • Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters and Established Date
  • Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Product Category
  • Figure Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
  • Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers
  • Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers
  • Table Mergers & Acquisitions, Expansion
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Regions (2012-2017)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)
  • Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Types (2012-2017)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Types (2012-2017)
  • Figure Revenue Share of Viral Vectors and Plasmid DNA Manufacturing by Types (2012-2017)
  • Figure 2016 Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Applications (2012-2017)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications in 2016
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)
  • Table BioReliance Company Profile
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of BioReliance 2016-2017
  • Table Cobra Biologics Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cobra Biologics
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cobra Biologics 2016-2017
  • Table Oxford BioMedica Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Oxford BioMedica
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Oxford BioMedica 2016-2017
  • Table UniQure Company Profile
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UniQure 2016-2017
  • Table FinVector Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FinVector
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FinVector 2016-2017
  • Table MolMed Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of MolMed
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MolMed 2016-2017
  • Table MassBiologics Company Profile
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MassBiologics 2016-2017
  • Table Richter-Helm Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Richter-Helm
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Richter-Helm 2016-2017
  • Table FUJIFILM Diosynth Biotechnologies Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FUJIFILM Diosynth Biotechnologies
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FUJIFILM Diosynth Biotechnologies 2016-2017
  • Table Lonza Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Lonza
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Lonza 2016-2017
  • Table Aldevron Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Aldevron
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Aldevron 2016-2017
  • Table Eurogentec Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Eurogentec
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Eurogentec 2016-2017
  • Table Cell and Gene Therapy Catapult Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cell and Gene Therapy Catapult
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cell and Gene Therapy Catapult 2016-2017
  • Table Biovian Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Biovian
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Biovian 2016-2017
  • Table Brammer Bio Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Brammer Bio
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Brammer Bio 2016-2017
  • Table VGXI Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of VGXI
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of VGXI 2016-2017
  • Table PlasmidFactory Company Profile
  • Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of PlasmidFactory
  • Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of PlasmidFactory 2016-2017
  • Table Key Raw Materials of Viral Vectors and Plasmid DNA Manufacturing
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing
  • Figure USA Labor Cost Analysis 2012-2016
  • Figure Cost of Employing a Factory Worker
  • Figure 2016 Estimated Labour Costs for the Whole Economy in Europe
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs 2013-2016
  • Table Average Price of Electricity to Ultimate Customers 2007-2016
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
  • Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
  • Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing
  • Figure Setting Pricing Policy
  • Figure Global GDP Growth Rate for 2016
  • Figure US GDP 2006-2016 (Billion USD)
  • Figure US CPI Change 2016-2017
  • Figure EU GDP 2006-2016 (Billion USD)
  • Figure EU CPI Change 2012-2016
  • Figure Germany GDP 2006-2016 (Billion USD)
  • Figure Germany CPI Change 2016-2017
  • Figure UK GDP 2006-2016 (Billion USD)
  • Figure UK CPI Change 2016-2017
  • Figure Italy GDP 2006-2016 (Billion USD)
  • Figure Italy CPI Change 2016-2017
  • Figure Japan GDP 2006-2016 (Billion USD)
  • Figure Japan CPI Change 2012-2016
  • Figure China GDP 2006-2016 (Billion USD)
  • Figure China CPI Change 2016-2017
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Regions (2017-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Regions (2017-2022)
  • Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Type (2017-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Type (2017-2022)
  • Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Application (2017-2022)
  • Figure Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2017-2022)
Back to Top
전화 문의
F A Q